Business

Recursion Publishes First Environmental, Social and Governance (ESG) Report

Releases inaugural report less than one year after becoming a publicly-traded company, demonstrating its strong commitment to ESG stewardshipAnnounces new

articleRecursion Pharmaceuticals, Inc.March 24, 20224/company/recursion-pharmaceuticals-inc/news/recursion-publishes-first-environmental-social-and-governance-esg-report-2022-03-24
Recursion Publishes First Environmental, Social and Governance (ESG) Report

About this update from Recursion Pharmaceuticals, Inc.

[{"type":"text","content":"Releases inaugural report less than one year after becoming a publicly-traded company, demonstrating its strong commitment to ESG stewardshipAnnounces new long-term commitments focused on net-zero greenhouse gas emissions, workforce diversity and philanthropySALT LAKE CITY, March 24, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX) today announced the release of its inaugural Environmental, Social and Governance (ESG) Report, highlighting the company's approach, practices and goals in several important areas such as its people and culture, community engagement, commitment to patients and environmental impact.\n\n \n \n \n \n \n \n\n \n\"Recursion has a strong foundation of corporate and social responsibility that has been a part of our company's DNA from the start,\" said Recursion Co-Founder & CEO Chris Gibson, Ph.D. \"This report gives us an opportunity to share the progress we've made, align our approach to external frameworks and standards, and establish new, ambitious goals we believe will have an important impact on society. Our ESG stewardship is both an integral part of our mission and essential to achieving it, and we believe deeply that committing to and investing in these areas will have a positive effect on our long-term success.\"\nAs part of its report, Recursion outlined several long-term ESG commitments, including:\nNet-Zero Greenhouse Gas (GHG) Emissions: The company aims to reduce or offset GHG emissions from its operations with a goal to become net-zero by the year 2030. This includes a near-term commitment to perform a detailed measurement and analysis of its emissions, with plans to disclose Scope 1 and 2 emissions in its next ESG Report.Equal Gender Representation: By 2030, the company aims for roughly equal representation of female and male genders (50/50 after considering non-binary representation) for (1) the whole company and (2) Vice President and above.The Recursion Foundation: Recursion will direct 1% of its equity into the Recursion Foundation, the company's non-profit entity established in 2019. The Foundation will continue to support the communities in which Recursion is based, with a focus on helping build sustainable, diverse and equitable life science and technology hubs; expanding STEM education opportunities for diverse youth; and directing and amplifying employee volunteerism into causes aligne...

More updates from Recursion Pharmaceuticals, Inc.